Recordati Rare Diseases Partners With the National Urea Cycle Disorders Foundation To Increase Awareness of the Risks of Hyperammonemia

Recordati Rare Diseases Inc., a biopharmaceutical company committed to providing orphan therapies to underserved rare disease communities in the U.S., today announced a new Check Ammonia awareness initiative. The campaign is intended to help healthcare practitioners (HCPs) recognize the signs and symptoms of hyperammonemia in infants, children and adults, act quickly to test ammonia levels, and to call a metabolic geneticist, as high ammonia levels can be toxic and may be the result of a rare metabolic disease. Created in collaboration with the National Urea Cycle Disorders Foundation (NUCDF), the…

Read More